Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration.
Yung-Hwi KimTae Kyu MoonYoung Sok JiPublished in: Ophthalmology and therapy (2024)
Early fluid-free status after switching to brolucizumab and choriocapillary function around CNV were prognostic factors for disease stability in nAMD refractory to anti-VEGF treatment.